No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes.

MLA

Audibert, Francois, et al. “No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes.” Journal of Obstetrics and Gynaecology Canada : JOGC = Journal d’obstetrique et Gynecologie Du Canada : JOGC, vol. 39, no. 9, Sept. 2017, pp. 805–17. EBSCOhost, https://doi.org/10.1016/j.jogc.2017.01.032.

APA

Audibert, F., De Bie, I., Johnson, J.-A., Okun, N., Wilson, R. D., Armour, C., Chitayat, D., & Kim, R. (2017). No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes. Journal of Obstetrics and Gynaecology Canada : JOGC = Journal d’obstetrique et Gynecologie Du Canada : JOGC, 39(9), 805–817. https://doi.org/10.1016/j.jogc.2017.01.032

Chicago

Audibert, Francois, Isabelle De Bie, Jo-Ann Johnson, Nanette Okun, R Douglas Wilson, Christine Armour, David Chitayat, and Raymond Kim. 2017. “No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes.” Journal of Obstetrics and Gynaecology Canada : JOGC = Journal d’obstetrique et Gynecologie Du Canada : JOGC 39 (9): 805–17. doi:10.1016/j.jogc.2017.01.032.